EI
CCXI

EAM Investors’s ChemoCentryx, Inc. CCXI Stock Holding History

EAM Investors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,932
Closed -$873K – 425
2020
Q3 		$873K Sell
15,932
-38,288
-71% -$2.06M 0.21% 233
2020
Q2 		$3.12M Sell
54,220
-41,311
-43% -$2.25M 0.69% 22
2020
Q1 		$3.84M Sell
95,531
-14,608
-13% -$620K 1.19% 4
2019
Q4 		$4.36M Buy
+110,139
New +$1.93M 0.96% 6

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

EAM Investors's CCXI Position: Q4 2020 in Review

EAM Investors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2020, closing a stake of 15,932 shares — an estimated $873K sold.

EAM Investors first reported a position in CCXI in Q4 2019 and held it in 4 quarters. The position peaked at $4.36M in Q4 2019. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

  • EAM Investors reported no remaining ChemoCentryx, Inc. position as of Q4 2020 after selling out during the quarter.
  • EAM Investors sold 15,932 ChemoCentryx, Inc. shares in Q4 2020, an estimated $873K.
  • EAM Investors first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 4 quarters.
  • EAM Investors's ChemoCentryx, Inc. position peaked at $4.36M in Q4 2019.
  • 196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.